CLINICAL_TRIALS
research
· 2025-09-10
Clinical Trial Update: 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT [Phase 2, Phase 3]
Summary
A Phase 2/3 trial comparing 99mTc Sestamibi SPECT/CT with 18F Fluorocholine PET/CT for locating Parathyroid Adenoma; recruitment is ongoing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Andrei Iagaru | Conditions: Parathyroid Adenoma | Phase 2, Phase 3 | Status: RECRUITING